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In this issue of Structure, Nolan and colleagues present the structure of BMP antagonist, PRDC, which
adopts a head-to-tail dimer with distinct structure and inhibitory mechanism compared to other dimeric an-
tagonists of the TGF-b superfamily, such as noggin.The transforming growth factor-beta
(TGF-b) superfamily is comprised of a
diversified family of secreted signaling
proteins, with more than 30 members in
humans and other vertebrates (Hinck,
2012). The proteins of the superfamily
evolved as developmental factors
responsible for embryonic patterning
and morphogenesis in invertebrates,
but have further evolved to regulate
numerous extraembryonic functions as
organisms have diversified. These in-
clude, but are not limited to, the regula-
tion of bone and muscle mass by BMP-7
andGDF-8, regulation of gonadal function
by the activins and inhibins, regulation of
the adaptive immune system by the
TGF-bs, and regulation of the differentia-
tion of embryonic stem cells by activins
and nodal. The proteins of the super-
family regulate hundreds of genes, and
thus it is not surprising that new functions,
such as the ability of BMPs to regulate the
differentiation of cancer stem cells in
cooperation with the secreted antagonist
coco, are still being discovered (Gao
et al., 2012).
TGF-bs, BMPs, GDFs, and other pro-
teins of the superfamily are structurally
similar, consisting of two extendedmono-
mers held together in most, but not all
cases, by a single disulfide bond
(Figure 1A) (Hinck, 2012). The monomers
of all superfamily members include a
cystine knot, which is formed by three
disulfides, where the first and second
bridge adjacent b strands, while a third
passes through the eight residue ring
formed by the first and second disulfide.
The extended b sheet structure, together
with the stabilizing cystine knot, is known
as a growth factor fold. This fold is present
in a number of other secreted signaling
proteins, including nerve growth factor
(NGF), platelet-derived growth factor(PDGF), vascular endothelial growth
factor (VEGF), and others (Figure 1B).
These signaling proteins are also active
as disulfide-linked dimers, though the
arrangement of monomers differs and is
responsible for their signaling through
distinct receptors and disparate activities
(Figure 1A).
The proteins of the TGF-b superfamily
signal by binding and bringing together
two transmembrane receptors, known
as receptor types I and II. The assembly
of these receptors into heteromeric com-
plexes leads to the activation of the type
I receptor kinase, which in turn activates
cytoplasmic effectors, known as Smads
(Massague´ et al., 2005). There are seven
type I receptors and five type II receptors
in most vertebrate species, and among
these, the type I receptors couple to two
different classes of Smads. The more
recently evolved members of the super-
family, including the TGF-bs, activins,
nodal, and some of the GDFs and BMPs
(GDF-9, -11, and -15 and BMP-15), bind
and signal through type I receptors that
activate R-Smads 2 and 3, while the
more distantly related GDFs (GDF-1, -3,
-5, -7, and -10) and BMPs (BMP-2, -3,
-4, -5, -6, -7, -8, -9, and -10) bind and
signal through type I receptors that
couple to and activate R-Smads 1, 5,
and 8 (Hinck, 2012). This restricts the
functional diversity that can be attained
through intrinsic differences in signaling.
The diversity of signaling is instead
dependent upon the unique patterns
with which the superfamily ligands are
targeted to different cells and tissues
and the context-dependent manner by
which cells respond to activated Smads
(Massague´ and Wotton, 2000).
The targeting of superfamily signaling
proteins is largely mediated by secreted
antagonists, which bind the signaling pro-Structure 21, August 6, 2013 ªteins and block the receptor binding sites.
The antagonists are structurally diverse,
ranging from large multidomain proteins,
such as follistatin and chordin, to smaller
single domain proteins with a cystine
knot growth factor fold, such as those of
the differential screening-selected gene
aberrative in neuroblastoma (DAN) family
and noggin (Bragdon et al., 2011). The
structural diversity of the antagonists
stands in contrast to the signaling pro-
teins and is thought to be responsible for
the specificity of most toward a limited
subset of signaling proteins. Though the
secreted antagonists have vital roles tar-
geting superfamily signaling proteins to
specific cells and tissues, there is, at pre-
sent, only a limitedmolecular understand-
ing of their diverse molecular structures
and inhibitory mechanisms (Cash et al.,
2009; Groppe et al., 2002).
The focusof theNolanet al. (2013; in this
issue of Structure) discussion is the DAN
family antagonist, protein related to DAN
and cerberus, or PRDC. Although all nine
members of the DAN family include a
cystine-knot motif and adopt a growth
factor fold, they differ significantly in their
inhibitory potencies and the subset of
signaling proteins they target. The most
potent DAN family antagonists, DAN,
PRDC, and Gremlin, are thought to only
antagonize BMPs and other superfamily
signaling proteins, while the least potent
of the DAN family antagonists, SOST and
USAG-1, also bind the coreceptor LRP5/
6 to antagonize Wnt signaling. The only
structural information available for the
DAN family of antagonists is SOST, which
includes an even number of cysteines and
is monomeric (Figure 1B) (Veverka et al.,
2009). This stands in contrast to PRDC,
which, through prior studies, had been
shown to form a highly stable noncovalent
dimer even though it includes an odd2013 Elsevier Ltd All rights reserved 1269
Figure 1. The Malleability of the Cystine Knot Growth Factor Fold
(A) Dimeric forms of the cystine-knotted signaling proteins, BMP-2 and VEGF-C, and the BMP antago-
nists, PRDC and noggin. Disulfide bonds that form the cystine knot, as well as those that form the inter-
chain disulfide(s) in BMP-2, VEGF-C, and noggin are depicted using a ball-and-stick representation.
Asterisks on the PRDC structure designate the BMP binding site as identified through site-directed muta-
genesis and accompanying functional studies.
(B) Monomeric forms of the cystine-knotted signaling proteins and the BMP antagonists shown in (A)
(shown also is the monomeric BMP antagonist SOST). Disulfide bonds that form the cystine knot are de-
picted using a ball-and-stick representation as in (A).
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Previewsnumber of cysteines, including one (C120)
that is positionally conserved with the
cysteine that forms the interchain disulfide
in TGF-bs and other proteins of the TGF-b
superfamily (Kattamuri et al., 2012). The
reason for this did not become apparent
until the structure of PRDC was deter-
mined and it was shown that PRDC forms
a head-to-tail dimer with an interface one-
and-a-half times larger than the signaling
proteins of the TGF-b superfamily and
extensive hydrogen bonding between
the exposed b strand of finger 2 (Fig-
ure 1A). This alternative manner of dimer-
ization positions the monomers so that
C120 is incapable of forming the inter-
chain disulfide characteristic of most
proteins of the TGF-b superfamily. The
authors further showed that the residues
of PRDC responsible for binding BMPs
reside largely on the convex surface of
the PRDC dimer in the cysteine-rich DAN1270 Structure 21, August 6, 2013 ª2013 Elsdomain. These findings suggest that
PRDC achieves high affinity for BMP
dimers due to multivalent binding (dimeric
PRDC binding to dimeric BMPs). The
more distantly related cystine-knot BMP
antagonist noggin was also previously
shown to bind BMPs with high affinity
by forming a dimer, but this differs in
two significant ways relative to PRDC.
The first is that, unlike PRDC, noggin
forms an unusual head-to-head dimer
that is stabilizedbothbyasingle interchain
disulfide and by the addition of several
helical segments that pack against one
another at the dimer interface (Figure 1A).
The second is that noggin also forms an
arch-like structure, but unlike PRDC, it
uses its concave surface, together with
an extended clamp-like structure, to
nearly fully surround the signaling protein
and block the type I and type II receptor
binding sites.evier Ltd All rights reservedThe structure of PRDC is significant,
because it shows how the same cystine-
knotted growth factor fold can be modi-
fied to form two entirely distinct BMP
antagonists. The finding that alternate
arrangements of the cystine-knotted
growth factor have given rise to distinct
antagonists with distinct specificities is
perhaps not surprising given the diversity
of the dimeric structures among the
different classes of cystine-knotted
growth factors (TGF-b, PDGF, NGF,
VEGF, etc.) and their binding to distinct
receptors. The structure of PRDC never-
theless reiterates the malleability of this
important structural motif and the many
ways in which it has evolved to expand
and diversify cell signaling. The future
studies of other DAN family antagonists,
such as gremlin, cerberus, coco, and
others, therefore promise to offer plenty
of additional surprises. We are looking
forward to seeing what else this domain
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